Milbepar 2.5 mg / 25 mg chewable tablets for small dogs and puppies
Milbepar 2.5 mg / 25 mg chewable tablets for small dogs and puppies
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
Milbepar 2.5 mg / 25 mg chewable tablets for small dogs and puppies
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime2.50/milligram(s)1.00Tablet
-
Praziquantel25.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Polyamide-Aluminium-Polyvinyl chloride / aluminium heat sealed blisters: Cardboard box with 1 blister of 2 tablets (2 tablets).
- Polyamide-Aluminium-Polyvinyl chloride / aluminium heat sealed blisters: Cardboard box with 2 blisters of 2 tablets (4 tablets).
- Polyamide-Aluminium-Polyvinyl chloride / aluminium heat sealed blisters: Cardboard box with 5 blisters of 2 tablets (10 tablets).
- Polyamide-Aluminium-Polyvinyl chloride / aluminium heat sealed blisters: Cardboard box with 12 blisters of 2 tablets (24 tablets).
- Polyamide-Aluminium-Polyvinyl chloride / aluminium heat sealed blisters: Cardboard box with 24 blisters of 2 tablets (48 tablets).
- Polyamide-Aluminium-Polyvinyl chloride / aluminium heat sealed blisters: Cardboard box with 50 blisters of 2 tablets (100 tablets).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4529681 1/2024
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0887/001
Concerned member states:
-
France
Generic of:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 15/10/2025
Summary of Product Characteristics
English (PDF)
Download Published on: 24/08/2025
French (PDF)
Published on: 22/07/2024
Combined File of all Documents
English (PDF)
Download Published on: 19/01/2026
ie-puar-mr-iev0887001-milbepar-25-mg--25-mg-chewable-tablets-for-small-d-en.pdf
English (PDF)
Download Published on: 26/08/2024